China approves inhaled CanSino vaccine for clinical trials

China's drug authority has approved for clinical trials an inhaled Covid-19 vaccine co-developed by domestic firm CanSino Biologics, the company said in a filing on Tuesday.

AFP

Latest news today on CanSino Biologics

China approves inhaled CanSino vaccine for clinical trials

Traders lament N500m losses in Mowe-Ofada market demolition

France, Spain and the risk of treating World Cup odds as certainty

VAR, cables & red cards: Why World Cup needs clearer trust before its biggest matches

PFIPC scandal: Adeyemi alleges threat to life, begs Tinubu for independent probe

China approves inhaled CanSino vaccine for clinical trials

The News You Need, Delivered To You.